Osteosarcoma of the Distal End of the Femur
Osteosarcoma is the most common primary malignant bone tumour, excluding myeloma and lymphoma. It usually affects the large bones of the arm or leg. It occurs most commonly in young people and affects more males than females. Also called osteogenic sarcoma. There is a predilection for the metaphyseal region of tubular long bones. 50% of cases occur around the knee.
SpiritIndia.com
serving better health information
Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Top | Articles

Osteosarcoma of the Distal End of the Femur

Osteosarcoma :: Osteosarcoma of the Distal End of the Femur

Osteosarcoma :: Osteosarcoma of the Distal End of the Femur

A retrospective multi-institutional study of 227 patients with osteosarcoma of the distal end of the femur was done to compare rates of local recurrence, metastasis, and survival.

Three cohorts of patients who had had either a limb-sparing procedure, an above-the-knee amputation, or disarticulation of the hip were compared. The results revealed prevalences of eight of seventy-three, nine of 115, and zero of thirty-nine as to local recurrence; forty-three of seventy-three, sixty-five of 115, and twenty-one of thirty-nine as to metastasis; and thirty-three of seventy-three, forty-eight of 115, and eighteen of thirty-nine as to death.

The Kaplan-Meier estimates of the percentage of patients who survived and the percentage of patients without recurrent disease showed no difference among the three surgical groups (Mantel-Cox test statistic: p = 0.8) after a median length of follow-up of five and one-half years. Various covariant adjusted estimates yielded similar results.

It appears that, compared with above-the-knee amputation or disarticulation of the hip, the use of a limb-salvage procedure for osteosarcoma of the distal end of the femur did not shorten the disease-free interval or compromise long-term survival.

(Published at www.spiritindia.com on Sunday, January 15, 2006)
»»   Pancreatic Cancer :: Cytokeratin 20 Expression Linked to Poor Survival
««   Lymphoma :: Response to Glucocorticoids Predicts Survival with CNS Lymphoma
The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
www.spiritindia.com - About us, Editorial Team, Authors, Testimonials, Linking us, Advertising, Advertisers, Recommend us, Feedback, Privacy policy, Disclaimer, Feedback
©2002-2008 SpiritIndia Group